Servicio de Cirugía General y del Aparato Digestivo. Hospital Universitario y Politécnico La Fe, Valencia, España.
Servicio de Cirugía General y del Aparato Digestivo. Hospital Universitario y Politécnico La Fe, Valencia, España.
Cir Esp (Engl Ed). 2020 Dec;98(10):598-604. doi: 10.1016/j.ciresp.2020.04.021. Epub 2020 Jun 3.
Nasogastric decompressive tube utilization has been accepted as one of the basic perioperative care measures after esophageal resection surgery. However, with the development of multimodal rehabilitation programs and without clear evidence to support their use, the systematic indication of this measure may be controversial.
Retrospective, descriptive and comparative study of patients who had undergone Ivor-Lewis esophagectomy in our center -from January 2015 to December 2018- with placement (Group S), or without placement (Group N) of a decompressive tube in gastroplasty during postoperative period. Epidemiological variables and differences between groups in post-surgical morbidity and mortality, hospital stay, onset of oral tolerance and the need for nasogastric tube placement were evaluated.
A total of 43 patients were included in this study, with a median age of 61 years, being 86% male. 46.5% were hypertensive, 25.5% had lung disease and 16.3% had diabetes mellitus. The median length of hospital stay was 9 days in group S versus 11.5 days in group N, with no differences in the onset of oral tolerance. Anastomotic dehiscence rate was 5% and 0% respectively. The overall mortality was 2.3% in the first 90 days, without differences between the groups. Placement of nasogastric tube during postoperative period was required only in 1 patient (4.3%) of the group N.
Non-use of nasogastric tube during postoperative period of an Ivor-Lewis esophagectomy is a safe measure, as it is not associated with a higher rate of complications or hospital stay. This fact may be able to improve patients' comfort and postoperative recovery.
鼻胃减压管的使用已被认为是食管切除术后基本围手术期护理措施之一。然而,随着多模式康复计划的发展,并且没有明确的证据支持其使用,该措施的系统适应证可能存在争议。
回顾性、描述性和比较研究,纳入 2015 年 1 月至 2018 年 12 月在我中心行 Ivor-Lewis 食管切除术的患者,术中胃成形术时放置(S 组)或不放置(N 组)减压管。评估术后发病率和死亡率、住院时间、口服耐受开始时间和需要放置鼻胃管的差异等。
共纳入 43 例患者,中位年龄 61 岁,86%为男性,46.5%为高血压,25.5%有肺部疾病,16.3%有糖尿病。S 组中位住院时间为 9 天,N 组为 11.5 天,两组口服耐受开始时间无差异。吻合口裂开率分别为 5%和 0%。90 天内总死亡率为 2.3%,两组间无差异。N 组仅 1 例(4.3%)需要放置鼻胃管。
Ivor-Lewis 食管切除术术后不使用鼻胃管是一种安全的措施,因为它与并发症或住院时间增加无关。这一事实可能有助于改善患者的舒适度和术后恢复。